...
首页> 外文期刊>Metabolic brain disease >Therapeutic effects of Cyperus rotundus rhizome extract on memory impairment, neurogenesis and mitochondria in beta-amyloid rat model of Alzheimer's disease
【24h】

Therapeutic effects of Cyperus rotundus rhizome extract on memory impairment, neurogenesis and mitochondria in beta-amyloid rat model of Alzheimer's disease

机译:Cypetus rotundus relundus resizom提取物对阿尔茨海默病β-淀粉样蛋白大鼠模型中记忆障碍,神经发生和线粒体的疗效

获取原文
获取原文并翻译 | 示例

摘要

Alzheimer's disease (AD) is a progressive neurodegenerative disturbance leading to memory deficit, cognitive decline, and behavioral disturbance. Deposition of Amyloid beta plaques, neurofibrillary tangle and mitochondrial impairment are common neuropathological signs in AD. In this study, the effect of standardized Cyperus rotundus(C. rotundus) extract in three different doses of 250, 500, and 750 mg/kg on memory, neurogenesis and mitochondrial mass in the beta amyloid rat model was assessed. For this purpose, 42 male Wistar rats were randomly divided into six groups (n = 7) to evaluate baseline training performance in Morris water maze test. Amyloid beta (A beta) was injected in animal hippocampal CA1 bilaterally in four groups. After 21 days, a decrease was observed in spending time in target quadrant in the first probe trial in A beta injected groups. Following that, 250, 500, and 750 mg/kg of C. rotundus extracts were administered to three out of four groups for a period of one month. BrdU (Bromodeoxyuridine) was intraperitoneally injected in all groups on the last 7 days of treatment. Then, 28 days after the last BrdU injection, the second probe trial was run, and rats were sacrificed. The neurogenesis and mitochondrial distribution were detected in hippocampus, by immunohistochemical staining. At last, it was observed that C. rotundus, almost recovered memory impairment, in addition to increasing in mitochondrial mass in CA1 and neurogenesis in dentate gyruse in the beta-amyloid rat model of Alzheimer's disease.
机译:阿尔茨海默病(AD)是一种渐进神经退行的干扰,导致记忆力赤字,认知下降和行为干扰。淀粉样蛋白β斑块,神经原纤维缠结和线粒体损伤的沉积是广告中常见的神经病理迹象。在该研究中,评估了β淀粉样蛋白大鼠模型中的三种不同剂量的250,500和750mg / kg的标准化Cyperus rotundus(c.圆形)提取物的作用。为此目的,将42只雄性Wistar大鼠随机分为六组(n = 7),以评估Morris水迷宫测试中的基线训练性能。淀粉样蛋白β(Aβ)在动物海马CA1中以四组分四组注射。 21天后,在β注射组中的第一个探针试验中在靶象限中花时间观察到减少。在此之后,将250,500和750mg / kg C.圆形萃取物施用至四组中的三个月,为期一个月。在治疗的最后7天内,Brdu(溴羰基尿苷)腹膜内注射所有群体。然后,在最后一次Brdu注射后28天,运行第二次探针试验,并处死大鼠。通过免疫组织化学染色在海马中检测到神经发生和线粒体分布。最后,观察到,除了在阿尔茨海默氏病的β-淀粉样蛋白大鼠模型中的CA1和神经发生中的线粒体质量增加,除了增加线粒体肿块和神经发生的情况外,还观察到几乎回收的记忆损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号